Atlas Trials

Hao Zeng

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hao Zeng

RecordFirmDate
Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy (NCT06523049)Hao Zeng2024-08-01
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma (NCT05808608)Hao Zeng2023-11-17

Track Hao Zeng automatically

Every clearance here is in the API, with alerts when new ones post.